American Ebola Patients Got Secret Serum

    Some of the ultrastructural morphology displayed by an Ebola virus virion is revealed in this undated handout colorized transmission electron micrograph (TEM) obtained by  Reuters August 1, 2014.  The 2014 Ebola outbreak is the worst since the disease was discovered in the mid-1970s, with 729 deaths in four different countries.  REUTERS/Frederick Murphy/CDC/Handout via Reuters  (UNITED STATES - Tags: HEALTH) THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY. IT IS DISTRIBUTED, EXACTLY AS RECEIVED BY REUTERS, AS A SERVICE TO CLIENTS. FOR EDITORIAL USE ONLY. NOT FOR SALE FOR MARKETING OR ADVERTISING CAMPAIGNS. MANDATORY CREDIT - RTR40YMW


    The National Institutes of Health provided the two Americans who contracted the Ebola virus with a experimental medicine that was flown top secret to Liberia. An insider source says that "ZMapp," a medicine yet to be tested on humans, was given to Kent Brantley and Nancy Writebol. Zmapp had been tested on four monkeys, but they received it within 48 hours of infection. Brantley had already been sick with Ebola for nine days before he received it. The two patients had to sign informed consent releases, but the drug appears to have helped them. Hours before it was administered, Brantley’s breathing was labored and he apparently said he believed he was dying. The day after he took the drug, he was showering on his own. ZMapp is not available to the general public, nor has it even gone through the clinical trial process.

    Read it at CNN